谷歌浏览器插件
订阅小程序
在清言上使用

Co-clinical Trial of Novel Bispecific anti-her2 Antibody Zanidatamab in Patient-derived Xenografts Developed on a Phase I Trial

ANNALS OF SURGICAL ONCOLOGY(2022)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要